|
Real-time Estimate
Cboe BZX
00:44:32 09/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 810.89 USD | -2.03% |
|
-1.59% | +5.03% |
| Market Cap | 82.65B 71.06B 66.86B 61.01B 114B 7,836B 114B 792B 306B 4,005B 310B 304B 12,745B | P/E 2026 * |
19.2x | P/E 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 75.78B 65.16B 61.3B 55.94B 104B 7,185B 105B 726B 281B 3,672B 285B 278B 11,686B | EV / Sales 2026 * |
4.48x | EV / Sales 2027 * | 3.91x |
| Free-Float |
71.06% | Yield 2026 * |
0.47% | Yield 2027 * | 0.54% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Boerse Muenchen
| RGO | Real-time | |
|
Tradegate
| RGO | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Xetra
| RGO | End-of-day quote | |
|
London S.E.
| 0R2M | Delayed | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript : Regeneron Pharmaceuticals, Inc.
| 1 day | -2.16% | ||
| 1 week | -1.59% | ||
| Current month | +1.46% | ||
| 1 month | +0.33% | ||
| 3 months | +32.61% | ||
| 6 months | +3.73% | ||
| Current year | +5.03% |
| 1 week | 799.42 |  | 859.34 |
| 1 month | 775.83 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 2/9/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 19/8/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.03% | -1.59% | +45.18% | -2.40% | 82.65B | |
| +0.94% | +1.88% | -16.46% | -34.82% | 59.87B | |
| -0.60% | -6.17% | +482.96% | +34.48% | 58.11B | |
| -1.77% | -5.14% | -9.07% | +29.36% | 50.35B | |
| -1.62% | -5.31% | -1.66% | +150.73% | 46.62B | |
| -3.40% | -1.23% | +50.97% | -17.61% | 32.63B | |
| -1.08% | +0.23% | +44.75% | +95.83% | 25.69B | |
| -1.09% | -3.47% | -2.81% | +183.45% | 22.49B | |
| +1.56% | -0.09% | +65.58% | +110.60% | 16.33B | |
| -3.15% | -9.92% | -24.27% | +747.29% | 14.79B | |
| Average | -1.27% | -0.23% | +63.52% | +129.69% | 40.95B | |
| Weighted average by Cap. | -1.28% | +0.82% | +82.39% | +66.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.92B 14.55B 13.69B 12.49B 23.31B 1,604B 23.43B 162B 62.74B 820B 63.54B 62.15B 2,609B | 18.42B 15.84B 14.9B 13.6B 25.37B 1,746B 25.5B 177B 68.29B 892B 69.16B 67.65B 2,840B |
| Net income | 4.77B 4.1B 3.86B 3.52B 6.58B 453B 6.61B 45.75B 17.7B 231B 17.92B 17.53B 736B | 5.45B 4.68B 4.4B 4.02B 7.5B 516B 7.54B 52.19B 20.19B 264B 20.45B 20B 840B |
| Net Debt | -6.87B -5.91B -5.56B -5.07B -9.46B -651B -9.51B -65.83B -25.47B -333B -25.79B -25.23B -1,059B | -10.55B -9.07B -8.54B -7.79B -14.54B -1,001B -14.61B -101B -39.13B -511B -39.63B -38.77B -1,627B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | US$812.00 | -1.90% | 187,816 |
| 04/09/26 | US$827.72 | -1.87% | 561,170 |
| 03/09/26 | US$843.47 | -1.00% | 496,255 |
| 02/09/26 | US$852.03 | +3.42% | 749,453 |
| 01/09/26 | US$823.82 | +3.10% | 682,806 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
